A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial
Antonio González-Martı́n, Luisa Sánchez‐Lorenzo, Nicoletta Colombo, René dePont Christensen, Florian Heitz, Mihai Meirovitz, Frédèric Selle, Toon Van Gorp, Núria Álvarez, Javier Sanchez, Carmen Hernández Marqúes
Topics & Concepts
AtezolizumabMedicineOvarian cancerOncologyRandomized controlled trialChemotherapyInternal medicineCancerPembrolizumabImmunotherapyPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentAdvanced Breast Cancer Therapies